|
MechanismHIV-1 protease inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
Mechanismα4β7 antagonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Gilead Pharmasset LLC
0 Patents (Medical) associated with Gilead Pharmasset LLC
100 Deals associated with Gilead Pharmasset LLC
100 Translational Medicine associated with Gilead Pharmasset LLC